{"downloaded": false, "htmlmade": false, "full": {"id": "34158845", "source": "MED", "pmid": "34158845", "pmcid": "PMC8210588", "fullTextIdList": {"fullTextId": "PMC8210588"}, "doi": "10.7150/thno.57745", "title": "Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives.", "authorString": "Gao J, Zhang Y, Liu X, Wu X, Huang L, Gao W.", "authorList": {"author": [{"fullName": "Gao J", "firstName": "Jie", "lastName": "Gao", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China."}, {"affiliation": "Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China."}, {"affiliation": "State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, Chinese Academy of Chinese Medical Sciences, Beijing, 100700, China."}]}}, {"fullName": "Zhang Y", "firstName": "Yifeng", "lastName": "Zhang", "initials": "Y", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China."}, {"affiliation": "Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China."}]}}, {"fullName": "Liu X", "firstName": "Xihong", "lastName": "Liu", "initials": "X", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Basic Medical College, Henan University of Chinese Medicine, Zhengzhou 450046, China."}}}, {"fullName": "Wu X", "firstName": "Xiayi", "lastName": "Wu", "initials": "X", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China."}}}, {"fullName": "Huang L", "firstName": "Luqi", "lastName": "Huang", "initials": "L", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "State Key Laboratory Breeding Base of Dao-di Herbs, National Resource Center for Chinese Materia Medica, Chinese Academy of Chinese Medical Sciences, Beijing, 100700, China."}}}, {"fullName": "Gao W", "firstName": "Wei", "lastName": "Gao", "initials": "W", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China."}, {"affiliation": "School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China."}, {"affiliation": "Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China."}]}}]}, "journalInfo": {"issue": "15", "volume": "11", "journalIssueId": "3191169", "dateOfPublication": "2021", "monthOfPublication": "0", "yearOfPublication": "2021", "printPublicationDate": "2021-01-01", "journal": {"title": "Theranostics", "ISOAbbreviation": "Theranostics", "medlineAbbreviation": "Theranostics", "NLMid": "101552395", "ISSN": "1838-7640", "ESSN": "1838-7640"}}, "pubYear": "2021", "pageInfo": "7199-7221", "abstractText": "Triptolide, an abietane-type diterpenoid isolated from <i>Tripterygium wilfordii</i> Hook. F., has significant pharmacological activity. Research results show that triptolide has obvious inhibitory effects on many solid tumors. Therefore, triptolide has become one of the lead compounds candidates for being the next \"blockbuster\" drug, and multiple triptolide derivatives have entered clinical research. An increasing number of researchers have developed triptolide synthesis methods to meet the clinical need. To provide new ideas for researchers in different disciplines and connect different disciplines with researchers aiming to solve scientific problems more efficiently, this article reviews the research progress made with analyzes of triptolide pharmacological activity, biosynthetic pathways, and chemical synthesis pathways and reported in toxicological and clinical studies of derivatives over the past 20 years, which have laid the foundation for subsequent researchers to study triptolide in many ways.", "affiliation": "School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic-eCollection", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "Y", "descriptorName": "Tripterygium", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "CH", "qualifierName": "chemistry", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Epoxy Compounds", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CS", "qualifierName": "chemical synthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "Y", "descriptorName": "Diterpenes", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CS", "qualifierName": "chemical synthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "Y", "descriptorName": "Phenanthrenes", "meshQualifierList": {"meshQualifier": [{"abbreviation": "CS", "qualifierName": "chemical synthesis", "majorTopic_YN": "N"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "Y", "descriptorName": "Antineoplastic Agents, Phytogenic", "meshQualifierList": {"meshQualifier": [{"abbreviation": "BI", "qualifierName": "biosynthesis", "majorTopic_YN": "N"}, {"abbreviation": "CS", "qualifierName": "chemical synthesis", "majorTopic_YN": "N"}, {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "N"}]}}]}, "keywordList": {"keyword": ["Biosynthesis", "Chemical synthesis", "Tripterygium wilfordii", "Biological activities", "Triptolide"]}, "chemicalList": {"chemical": [{"name": "Diterpenes", "registryNumber": "0"}, {"name": "Antineoplastic Agents, Phytogenic", "registryNumber": "0"}, {"name": "Phenanthrenes", "registryNumber": "0"}, {"name": "Epoxy Compounds", "registryNumber": "0"}, {"name": "triptolide", "registryNumber": "19ALD1S53J"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.7150/thno.57745"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8210588"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8210588?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "N", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2021-07-29", "dateOfCreation": "2021-06-23", "firstIndexDate": "2021-06-24", "fullTextReceivedDate": "2021-06-23", "dateOfRevision": "2021-07-29", "electronicPublicationDate": "2021-05-24", "firstPublicationDate": "2021-05-24"}, "htmllinks": "https://europepmc.org/articles/PMC8210588", "abstract": "Triptolide, an abietane-type diterpenoid isolated from <i>Tripterygium wilfordii</i> Hook. F., has significant pharmacological activity. Research results show that triptolide has obvious inhibitory effects on many solid tumors. Therefore, triptolide has become one of the lead compounds candidates for being the next \"blockbuster\" drug, and multiple triptolide derivatives have entered clinical research. An increasing number of researchers have developed triptolide synthesis methods to meet the clinical need. To provide new ideas for researchers in different disciplines and connect different disciplines with researchers aiming to solve scientific problems more efficiently, this article reviews the research progress made with analyzes of triptolide pharmacological activity, biosynthetic pathways, and chemical synthesis pathways and reported in toxicological and clinical studies of derivatives over the past 20 years, which have laid the foundation for subsequent researchers to study triptolide in many ways.", "Keywords": ["Biosynthesis", "Chemical synthesis", "Tripterygium wilfordii", "Biological activities", "Triptolide"], "pdflinks": "https://europepmc.org/articles/PMC8210588?pdf=render", "journaltitle": "Theranostics", "authorinfo": ["Gao J", "Zhang Y", "Liu X", "Wu X", "Huang L", "Gao W"], "title": "Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives."}